{"filing":{"accession_number":"0001104659-26-075451","cik":"0001761612","ticker":"BCYC","company_name":"BICYCLE THERAPEUTICS PLC","form":"8-K","filing_date":"2026-06-18","report_date":null,"primary_document":"tm2618222d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465926075451/tm2618222d1_8k.htm"},"events":[{"id":11719,"run_id":10302,"accession_number":"0001104659-26-075451","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder voting results from Bicycle Therapeutics' annual general meeting held on June 17, 2026. The filing reports the outcomes of nine proposals including director re-elections (Felix Baker, Hervé Hoppenot), advisory approval of named executive officer compensation, auditor ratification and re-appointment, and approval of remuneration policies. All proposals passed with substantial majorities, as required by Item 5.07 of Form 8-K.","company_name":"BICYCLE THERAPEUTICS PLC","ticker":"BCYC","filing_date":"2026-06-18","form":"8-K","submitted_at":null,"items":[{"id":8376,"accession_number":"0001104659-26-075451","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from Bicycle Therapeutics' annual general meeting held on June 17, 2026. The filing reports the outcomes of nine proposals including director re-elections (Felix Baker, Hervé Hoppenot), advisory approval of named executive officer compensation, auditor ratification and re-appointment, and approval of remuneration policies. All proposals passed with substantial majorities, as required by Item 5.07 of Form 8-K.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T12:22:14.066346+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":8376,"accession_number":"0001104659-26-075451","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from Bicycle Therapeutics' annual general meeting held on June 17, 2026. The filing reports the outcomes of nine proposals including director re-elections (Felix Baker, Hervé Hoppenot), advisory approval of named executive officer compensation, auditor ratification and re-appointment, and approval of remuneration policies. All proposals passed with substantial majorities, as required by Item 5.07 of Form 8-K.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T12:22:14.066346+00:00","company_name":"BICYCLE THERAPEUTICS PLC","ticker":"BCYC","filing_date":"2026-06-18"}]}